Crossmark Global Holdings’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-36,660	Closed	-$589K	–	1389
2021 Q3	$589K	Hold	36,660	–	–	0.01%	840
2021 Q2	$507K	Buy	36,660 +150	+0.4%	+$2.07K	0.01%	923
2021 Q1	$533K	Buy	36,510 +40	+0.1%	+$584	0.01%	871
2020 Q4	$634K	Buy	+36,470	New	+$634K	0.02%	745